Weiss Multi-Strategy Advisers’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio CNCE Stock Details CNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-25,000	Closed	-$379K	–	551
2015 Q1	$379K	Sell	25,000 -4,000	-14%	-$55.8K	0.02%	384
2014 Q4	$386K	Sell	29,000 -1,000	-3%	-$12.9K	0.01%	353
2014 Q3	$378K	Sell	30,000 -7,000	-19%	-$67.9K	0.01%	458
2014 Q2	$374K	Sell	37,000 -9,800	-21%	-$94.6K	0.01%	568
2014 Q1	$629K	Buy	+46,800	New	+$661K	0.01%	584

Other funds holding CNCE

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

SAM

Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Weiss Multi-Strategy Advisers's CNCE Position: Q2 2015 in Review

Weiss Multi-Strategy Advisers sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q2 2015, closing a stake of 25,000 shares — an estimated $379K sold.

Weiss Multi-Strategy Advisers first reported a position in CNCE in Q1 2014 and held it in 5 quarters. The position peaked at $629K in Q1 2014. 67 funds tracked by Wall St. Rank hold CNCE as of Q2 2015.

Weiss Multi-Strategy Advisers reported no remaining Concert Pharmaceuticals, Inc. position as of Q2 2015 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 25,000 Concert Pharmaceuticals, Inc. shares in Q2 2015, an estimated $379K.
Weiss Multi-Strategy Advisers first reported a position in Concert Pharmaceuticals, Inc. in Q1 2014 and held it in 5 quarters.
Weiss Multi-Strategy Advisers's Concert Pharmaceuticals, Inc. position peaked at $629K in Q1 2014.
67 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q2 2015.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q2 2015, filed 14 Aug 2015.